Results 1 to 10 of about 22,059 (114)

Development and evaluation of the first-in-class nanobody based PET tracer targeting human inducible T-cell co-stimulator receptor [PDF]

open access: yesEJNMMI Research
Background Inducible T-cell co-stimulator receptor (ICOS) is a conserved biomarker mainly expressed on activated T cells. It had been proved that PET imaging targeting ICOS was a promising strategy for assessment of immune responses in cancer ...
Jianming Li   +6 more
doaj   +2 more sources

ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases

open access: yesFrontiers in Immunology, 2020
Recent studies have reported the pathological effect of ICOS+ T cells, but ICOS signals also widely participate in anti-inflammatory responses, particularly ICOS+ regulatory T (Treg) cells.
Xian-Zhi Xiong
exaly   +3 more sources

ICOS Co-Stimulation: Friend or Foe?

open access: yesFrontiers in Immunology, 2016
Over the last 15 years, the inducible T cell co-stimulator (ICOS) has been implicated in a wide variety of immune outcomes, including the induction and regulation of Th1, Th2, and Th17 immunity.
Daniel J Wikenheiser   +2 more
exaly   +3 more sources

Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome [PDF]

open access: yesCancer Immunology, Immunotherapy
Objectives Inducible T cell costimulator (ICOS) is a CD28-family costimulatory receptor with bidirectional therapeutic effects on antitumor immunity, and HLA-mediated tumor recognition is essential for effective T cell responses.
Hiroyuki Yamada   +11 more
doaj   +2 more sources

ICOS+ T helper 2 cells promote the pulmonary fibrosis in systemic sclerosis [PDF]

open access: yesMolecular Medicine
Background Interstitial lung disease (ILD) is the most frequent complication of systemic sclerosis (SSc), associated with a poor prognosis and limited treatments.
Huimin Zhu   +9 more
doaj   +2 more sources

Inducible T‐Cell Co‐Stimulator (ICOS) and ICOS Ligand: Dealing With a Two‐Faced Cancer Immunoregulatory System [PDF]

open access: yesCancer Medicine
Background ICOS (inducible T‐cell co‐stimulator) and ICOS ligand (ICOSL) are part of an important, complex pathway that can lead to both immune stimulation and suppression.
Mina Nikanjam   +9 more
doaj   +2 more sources

A view of the European carbon flux landscape through the lens of the ICOS atmospheric observation network [PDF]

open access: yesAtmospheric Chemistry and Physics, 2023
The ICOS (Integrated Carbon Observation System) network of atmospheric measurement stations produces standardized data on greenhouse gas concentrations at 46 stations in 16 different European countries (March 2023).
I. Storm   +6 more
doaj   +1 more source

Levels and clinical significance of follicular helper T cells in peripheral blood of syphilis patients

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Objective To investigate the levels of different follicular helper T cells in peripheral blood of syphilis patients and discuss its clinical significance.
Kaixi PAN   +4 more
doaj   +1 more source

Versioning biological cells for trustworthy cell engineering

open access: yesNature Communications, 2022
Full traceability and transparency are important to establish trust in engineered cell lines. Here the authors argue that version control for cell engineering marks a significant step toward more open, reproducible, traceable and ultimately more ...
Jonathan Tellechea-Luzardo   +6 more
doaj   +1 more source

Financial Bubbles for Economic Development: Implications Regarding ICOs

open access: yesStudies in Business and Economics, 2021
Most people consider financial bubbles as the result of speculations and manipulations, and that less of them will make a market economy more efficient. While speculative bubbles no doubt increase the risks and uncertainties of investors, there are many ...
Lorne Frank, Li Tianze
doaj   +1 more source

Home - About - Disclaimer - Privacy